Targeted disruption of p107: Functional overlap between p107 and Rb

Genes and Development

Volumn 10, Issue 13, 1996, Pages 1621-1632

  Lee, Myung Ho ^a,f   Williams, Bart O ^c   Mulligan, George ^b,c   Mukai, Shizuo ^d   Bronson, Roderick T ^e   Dyson, Nicholas ^a   Harlow, Ed ^a   Jacks, Tyler ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e TUFTS UNIVERSITY   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; gene targeting; liver; p107; Rb; retinal dysplasia

Indexed keywords

RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; ETIOLOGY; FEMALE; GENE DISRUPTION; GENE TARGETING; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GROWTH RETARDATION; HOMOZYGOSITY; MALE; MORTALITY; MOUSE; MOUSE MUTANT; MUTATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RETINA MALFORMATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0029736909     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.13.1621     Document Type: Article

References (49)

1. Al-Ubaidi, M.R., R.L. Font, A.B. Quiambao, M.J. Keener, G.I. Liou, P.A. Overbeek, and W. Baehr. 1992. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphoto-receptor retinoid-binding protein promoter. J. Cell Biol. 119: 1681-1687.
2. Beijersbergen, R.L., R.M. Kerkhoven, L. Zhu, L. Carlee, P. Marthijs Voorhoeve, and R. Bernards. 1994a. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes & Dev. 8: 2680-2690.
3. Beijersbergen, R.L., E.M. Hijmans, L. Zhu, and R. Bernards. 1994b. Interaction of c-Myc with the pRB-related protein p 107 results in inhibition of c-Myc-mediated transactiva tion. EMBO J. 13: 4080-4086.
4. Cao, L., B. Faha, M. Demski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176-179.
5. Cavenee, W.K., T.P. Dryja, R.A. Philips, W.F. Benedict, R. Godbout, B.L. Gallic, A.L. Murphree, L.C. Strong, and R.L. White. 1983. Expression of recessive alleles by chromosomal mechanism in retinoblastoma. Nature 305: 779-784.
6. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162: 156-159.
7. Clarke, A.R., E.R. Maandag, M. van Roon, N.M.T. van der Lugt, M. van der Valk, M.L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
8. Claudio, P.P., C.M. Howard, A. Baldi, A. De Luca, Y. Fu, G. Condorelli, Y. Sun, N. Colburn, B. Calabretta, and A. Giordano. 1994. p130/pRB2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRB and p107. Cancer Res. 54: 5556-5560.
9. Cobrinik, D., P. Whyte, D.S. Peeper, T. Jacks, and R.A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 ElA-binding protein. Genes & Dev. 7: 2392-2404.
10. Cobrinik, D., M.-H. Lee, G. Hannon, G. Mulligan, R.T. Bronson, N. Dyson, E. Harlow, D. Beach, R.A. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p 130 and p107 proteins in limb development. Genes & Dev. (this issue).
11. Dryja, T.P., W. Cavenee, R. White, J.M. Rapaport, R. Peterson, D.M. Albert, and G.A.P. Bruns. 1984. Homozygosity of chromosome 13 in retinoblastoma. N. Engl. J. Med. 310: 550-553.
12. Endo, T. 1992. SV40 large T inhibits myogenic differentiation partially through inducing c-jun. J. Biol. Chem. 112: 321-329.
13. Ewen, M.E., B. Faha, E. Harlow, and D. Livingston. 1992. Interaction of p 107 with cyclin A independent of complex formation with viral oncoproteins. Science 255: 85-87.
14. Friend, S.H., R. Bernards, S. Rogelj, R.A. Weinberg, J.M. Rapaport, D.M. Albert, and T.P. Dryja. 1986. A human DNA segment with properties of the gene that predispose to retinoblastoma and osteosarcoma. Nature 323: 643-646.
15. Fung, Y.-K.T., A.L. Murphree, A. T'Ang, J. Qian, S.H. Hinrichs, and W.F. Benedict. 1987. Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657-1661.
16. Ginsberg, D., G. Vairo, T. Chittenden, Z.-X. Xiao, G. Xu, K.L. Wydner, J.A. DeCaprio, J.B. Lawrence, and D. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes & Dev. 8: 2665-2679.
17. Gossler, A., T. Doetschman, R. Korn, E. Serfling, and R. Kemler. 1986. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. 83: 9065-9069.
18. Gu, W., J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309-324.
19. Gu, W., K. Bhatia, I.T. Magrath, C.V. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the myc transcriptional activation domain by p 107. Science 264: 251-254.
20. Harbour, J.W., S.-L. Lai, J. Whang-Peng, A.F. Gazdar, J.D. Minna, and F.J. Kaye. 1988. Abnormalities in structure and expression of the retinoblastoma gene in SCLC. Science 241: 353-357.
21. Hijmans, E.M., P.M. Voorhoeve, R.L. Beijersbergen, L.J. van't Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15: 3082-3089.
22. Hoang, A.T., B. Lutterbach, B.C. Lewis, T. Yano, T.Y. Chou, J.F. Barrett, M. Raffeid, S.R. Hann, and C.V. Dang. 1995. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p!07, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15: 4031-4042.
23. Horowitz, J.M., D.W. Yandell, S.-H. Park, S. Canning, P. Whyte, K. Buchkovich, E. Harlow, R.A. Weinberg, and T.P. Dryja. 1989. Point mutation inactivation of the retinoblastoma antioncogene. Science 243: 937-940.
24. Horowitz, J.M., S.-H. Park, E. Bogenmann, J.-C. Cheng, D.W. Yandell, F.J. Kaye, I.D. Minna, T.P. Dryja, and R.A. Weinberg. 1990. Frequent inactivation of the retinoblastoma antioncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. 87: 2775-2779.
25. Howes, K.A., N. Ransom, D.S. Papermaster, J.G.H. Lasudry, D.M. Albert, and J.J. Windle. 1994. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes & Dev. 8: 1300-1310.
26. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
27. Kim, K.K., M.H. Soonpaa, A.I. Daud, G.Y. Koh, J.S. Kim, and L.J. Field. 1994. Tumor suppressor gene expression during normal and pathological myocardial growth. J. Biol. Chem. 269: 22607-22613.
28. Lee, E.Y.-H.P., H. To, J.-Y. Shew, R. Bookstein, P. Scully, and W.-H. Lee. 1988. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241: 218-221.
29. Lee, E.Y.-H.P., C.-Y. Chang., N. Hu, Y.-C. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
30. Lee, W.-H., R. Bookstein, F. Hong, L.-J. Young, J.-Y. Shew, and E.Y.-H.P. Lee. 1987. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 235: 1394-1399.
31. Lees, J.A., M. Saito, M. Vidai, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13: 7813-7825.
32. Maandag, E.C.R., M. van der Valk, M. Vlaar, C. Feltkamp, J. O'Brien, M. van Roon, N. van der Lugt, A. Berns, and H. te Riele. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13: 4260-4268.
33. Maione, R., G.M. Fimia, and P. Amati. 1992. Inhibition of in vitro myogenic differentiation by a polyoma virus early function. Oncogene 7: 85-93.
34. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to nonselectable genes. Nature 336: 348-352.
35. Morgenbesser, S.D., B.O. Williams, T. Jacks, and R.A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72-74.
36. Qin, X.-Q., D.M. Livingston, M. Ewen, W.R. Sellers, Z. Arany, and W.G. Kaelin Jr. 1995. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15: 742-755.
37. -/- muscle cells. Science 264: 1467-1471.
38. Schwarz, J.K., S.H. Deveto, E.J. Smith, S.P. Chellappan, L. Jakoi, and J.R. Nevins. 1993. Interaction of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12: 1013-1020.
39. Shirodkar, S., M. Ewen, J.A. DeCaprio, J. Morgan, D.M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157-166.
40. T'Ang, A., J.M. Varley, S. Chakraborty, A.L. Murphree, and Y.-K.T. Fung. 1988. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242: 263-266.
41. Toguchida, J., K. Ishizaki, M.S. Sasaki, Y. Nakamura, M. Ikenaga, M. Kato, M. Sugimoto, Y. Kotoura, and T. Yamamuro. 1989. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 338: 156-158.
42. Tybulewicz, V.L.G., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-ab1 protooncogene. Cell 65: 1153-1163.
43. Vairo, G., D.M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes & Dev. 9: 869-881.
44. Webster, K.A., G.E. Muscat, and L. Kedes. 1988. Adenovirus El A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature 332: 553-557.
45. Williams, B.O., E.M. Schmitt, L. Remington, R.T. Bronson, D.M. Albert, R.A. Weinberg, and T. Jacks. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13: 4251-4259.
46. Windle, J.J., D.M. Albert, J.M. O'Brian, D.M. Marcus, C.M. Disteche, R. Bernards, and P.L. Mellon. 1990. Retinoblastoma in transgenic mice. Nature 343: 665-669.
47. Yokota, J., T. Akiyama, Y.-K.T. Fung, W.F. Benedict, Y. Namba, M. Hanaoka, M. Wada, T. Terasaki, Y. Shimosato, T. Sugimura, and M. Terad. 1988. Altered expression of the retinoblastoma (Rb] gene in small-cell carcinoma of the lung. Oncogene 3: 471-475.
48. Zhu, L., S. van den Heuvel, K. Heiin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes & Dev. 7: 1111-1125.
49. Zhu, L., G. Enders, J. Lees, R.L. Beijersbergen, R. Bernards, and E. Harlow. 1995. The pRB-related protein p107 contains two growth suppression domains: Independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14: 1904-1913.